Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation

Overview

Journal Clin Exp Pharmacol

Date 2021 Sep 15

PMID 34522469

Citations 4

Authors

Vatsalya Vatsalya

Fengyuan Li

Jane Frimodig

Nihar Shah

Amar Sutrawe

Wenke Feng

Affiliations

Soon will be listed here.

Abstract

Background: Hyperuricemia has been reported in liver injury; however its role in the early stage of Alcohol-associated Liver Disease (ALD) has not been examined yet. This study investigated the role of Serum Uric Acid (SUA) in alcohol-related liver disease, gut barrier dysfunction, and inflammation activity. This study also evaluated the efficacy of abstinence, treatment with thiamine and medical management to alleviate hyperuricemia.

Methods: 48 heavy drinking Alcohol Use Disorder (AUD) patients (34 males [M]/14 females [F]) participated in this study. Patients were grouped by serum Alanine Aminotransferase (ALT) levels as group 1 (ALT ≤ 40 U/L, 7M/8F) and group 2 (ALT>41U/L, 27M/6F). All patients received open label thiamine 200 mg daily dose. Demographics, drinking history (using Lifetime Drinking History [LTDH], and Timeline Follow Back [TLFB] for the past 90 days) reports were collected at baseline. Baseline and three-week assessments for SUA, biomarkers of liver injury, endotoxemia and inflammation were evaluated.

Results: 22 out of 48 AUD patients reported hyperuricemia, primarily in males. SUA was significantly associated with ALT in each group (in group 2, when covaried with HDD90). SUA was also significantly associated with gut barrier dysfunction markers, LBP and LPS, in group 2, SUA and LBP predicted IL-1 significantly in group 2. Uric acid along with IL-1 and HDD90 significantly predicted necrotic type of hepatocyte cell death in group 2. Post-treatment SUA dropped across both the groups, significantly in females; adverse effects of drinking, cytokine and uric acid interaction on liver cell death also decreased in group 2. experiments validated the efficacy of thiamine on hepatocytic uric acid production in alcohol sensitization.

Conclusion: Uric acid, a metabolic risk signal, was likely involved in the interaction of proinflammatory activity with heavy drinking markers at early-stage ALD. Three-week inpatient medical management, along with treatment with thiamine, seems to alleviate baseline hyperuricemia and necrotic type of hepatocytic cell death in AUD patients with liver injury.

Citing Articles

Association between vitamin B1 intake and hyperuricemia in adults.

Li Y, Xu X, Xu X, Yang X, Dai Y, Song D Sci Rep. 2024; 14(1):16428.

PMID: 39013961 PMC: 11252358. DOI: 10.1038/s41598-024-66384-4.

One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.

Sagaram M, Frimodig J, Jayanty D, Hu H, Royer A, Bruner R Front Immunol. 2024; 14:1202267.

PMID: 38162671 PMC: 10755956. DOI: 10.3389/fimmu.2023.1202267.

Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis.

Sagaram M, Parthasarathy R, Condon S, Closson C, Kong M, Schwandt M Int J Mol Sci. 2022; 23(10).

PMID: 35628661 PMC: 9143806. DOI: 10.3390/ijms23105852.

Dietary Pattern Associated with the Risk of Hyperuricemia in Chinese Elderly: Result from China Nutrition and Health Surveillance 2015-2017.

Yang Y, Piao W, Huang K, Fang H, Ju L, Zhao L Nutrients. 2022; 14(4).

PMID: 35215493 PMC: 8875556. DOI: 10.3390/nu14040844.

References

Liese A, Hense H, Lowel H, Doring A, Tietze M, Keil U . Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology. 1999; 10(4):391-7. DOI: 10.1097/00001648-199907000-00006. View

Scriver C, Mackenzie S, Clow C, Delvin E . Thiamine-responsive maple-syrup-urine disease. Lancet. 1971; 1(7694):310-2. DOI: 10.1016/s0140-6736(71)91041-5. View

Gordon T, Kannel W . Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study. Arch Intern Med. 1983; 143(7):1366-74. View

Li F, Zhao C, Shao T, Liu Y, Gu Z, Jiang M . Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation. J Pathol. 2020; 252(4):371-383. PMC: 8006217. DOI: 10.1002/path.5531. View

Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View

Sobell L, Sobell M, Connors G, Agrawal S . Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success. Alcohol Clin Exp Res. 2003; 27(10):1661-6. DOI: 10.1097/01.ALC.0000091227.26627.75. View

Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V . Regulation of uric acid metabolism and excretion. Int J Cardiol. 2015; 213:8-14. DOI: 10.1016/j.ijcard.2015.08.109. View

Sussman N, Lucey M . Alcohol and Alcoholic Liver Disease. Clin Liver Dis. 2018; 23(1):xiii-xiv. DOI: 10.1016/j.cld.2018.10.001. View

Tanaka T, Yamamoto D, Sato T, Tanaka S, Usui K, Manabe M . Adenosine thiamine triphosphate (AThTP) inhibits poly(ADP-ribose) polymerase-1 (PARP-1) activity. J Nutr Sci Vitaminol (Tokyo). 2011; 57(2):192-6. DOI: 10.3177/jnsv.57.192. View

10.

Lieber C, Jones D, Losowsky M, Davidson C . Interrelation of uric acid and ethanol metabolism in man. J Clin Invest. 1962; 41:1863-70. PMC: 291111. DOI: 10.1172/JCI104643. View

11.

Vatsalya V, Song M, Schwandt M, Cave M, Barve S, George D . Effects of Sex, Drinking History, and Omega-3 and Omega-6 Fatty Acids Dysregulation on the Onset of Liver Injury in Very Heavy Drinking Alcohol-Dependent Patients. Alcohol Clin Exp Res. 2016; 40(10):2085-2093. PMC: 5367046. DOI: 10.1111/acer.13197. View

12.

Balakumar P, Sharma R, Singh M . Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Pharmacol Res. 2008; 58(5-6):356-63. DOI: 10.1016/j.phrs.2008.09.012. View

13.

Gao B, Tsukamoto H . Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?. Gastroenterology. 2016; 150(8):1704-9. PMC: 4887345. DOI: 10.1053/j.gastro.2016.01.025. View

14.

Lyngdoh T, Marques-Vidal P, Paccaud F, Preisig M, Waeber G, Bochud M . Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 2011; 6(5):e19901. PMC: 3098830. DOI: 10.1371/journal.pone.0019901. View

15.

Thomson A . Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl. 2001; 35(1):2-7. DOI: 10.1093/alcalc/35.supplement_1.2. View

16.

LUKIENKO P, Melnichenko N, Zverinskii I, Zabrodskaya S . Antioxidant properties of thiamine. Bull Exp Biol Med. 2001; 130(9):874-6. View

17.

Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R . Is it time to revise the normal range of serum uric acid levels?. Eur Rev Med Pharmacol Sci. 2014; 18(9):1295-306. View

18.

DRUM D, Goldman P, Jankowski C . Elevation of serum uric acid as a clue to alcohol abuse. Arch Intern Med. 1981; 141(4):477-9. View

19.

Milanesi S, Verzola D, Cappadona F, Bonino B, Murugavel A, Pontremoli R . Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. J Cell Physiol. 2018; 234(7):10868-10876. DOI: 10.1002/jcp.27929. View

20.

Vatsalya V, Kong M, Cave M, Liu N, Schwandt M, George D . Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients. J Nutr Biochem. 2018; 59:49-55. PMC: 6129416. DOI: 10.1016/j.jnutbio.2018.05.003. View